Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,425 | 7 | 79.7% |
| Travel and Lodging | $4,141 | 15 | 17.9% |
| Food and Beverage | $566.21 | 12 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $23,132 | 34 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $3,075 | 4 | Merck Sharp & Dohme Corporation ($3,075) |
| 2019 | $18,926 | 25 | Merck Sharp & Dohme Corporation ($18,926) |
| 2018 | $1,131 | 5 | Merck Sharp & Dohme Corporation ($1,131) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 07/22/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| 07/17/2020 | Merck Sharp & Dohme Corporation | MK-8591 (Drug) | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/15/2020 | Merck Sharp & Dohme Corporation | MK-8591 (Drug) | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/11/2019 | Merck Sharp & Dohme Corporation | DELSTRIGO (Drug) | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/11/2019 | Merck Sharp & Dohme Corporation | DELSTRIGO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/18/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $48.79 | General |
| 09/18/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $43.51 | General |
| 09/18/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $14.94 | General |
| 09/17/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $243.10 | General |
| 09/17/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $68.52 | General |
| 09/17/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 09/17/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $44.81 | General |
| 09/17/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $29.89 | General |
| 09/16/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $243.10 | General |
| 09/16/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $125.79 | General |
| 09/15/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $170.21 | General |
| 08/02/2019 | Merck Sharp & Dohme Corporation | DELSTRIGO (Drug) | Consulting Fee | Cash or cash equivalent | $4,675.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/02/2019 | Merck Sharp & Dohme Corporation | DELSTRIGO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/21/2019 | Merck Sharp & Dohme Corporation | MK-8591 (Drug) | Travel and Lodging | In-kind items and services | $1,446.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/21/2019 | Merck Sharp & Dohme Corporation | MK-8591 (Drug) | Travel and Lodging | In-kind items and services | $89.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/21/2019 | Merck Sharp & Dohme Corporation | MK-8591 (Drug) | Travel and Lodging | In-kind items and services | $89.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/21/2019 | Merck Sharp & Dohme Corporation | MK-8591 (Drug) | Food and Beverage | In-kind items and services | $72.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/21/2019 | Merck Sharp & Dohme Corporation | MK-8591 (Drug) | Food and Beverage | In-kind items and services | $51.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/21/2019 | Merck Sharp & Dohme Corporation | MK-8591 (Drug) | Food and Beverage | In-kind items and services | $42.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 79 | 142 | $62,014 | $13,458 |
| 2022 | 3 | 59 | 99 | $36,189 | $7,711 |
| 2021 | 3 | 42 | 70 | $20,341 | $4,354 |
| 2020 | 2 | 27 | 59 | $17,365 | $3,459 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 88 | $37,094 | $8,799 | 23.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $11,270 | $2,056 | 18.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 16 | 16 | $7,062 | $1,564 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $6,588 | $1,039 | 15.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 59 | $24,013 | $5,180 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 29 | $7,820 | $1,609 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 11 | $4,356 | $922.17 | 21.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 39 | $11,505 | $2,425 | 21.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 16 | $5,300 | $1,140 | 21.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 15 | $3,536 | $789.07 | 22.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 45 | $13,095 | $2,858 | 21.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 14 | 14 | $4,270 | $601.22 | 14.1% |
About Dr. Jessica Haberer, M.D
Dr. Jessica Haberer, M.D is a Internal Medicine healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417022831.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jessica Haberer, M.D has received a total of $23,132 in payments from pharmaceutical and medical device companies, with $3,075 received in 2020. These payments were reported across 34 transactions from 1 company. The most common payment nature is "Consulting Fee" ($18,425).
As a Medicare-enrolled provider, Haberer has provided services to 207 Medicare beneficiaries, totaling 370 services with total Medicare billing of $28,982. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location San Francisco, CA
- Active Since 11/21/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1417022831
Products in Payments
- DELSTRIGO (Drug) $10,975
- MK-8591 (Drug) $2,794
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in San Francisco
Dr. Fred Cohen, M.d, M.D
Internal Medicine — Payments: $1.6M
John Teerlink, M.d, M.D
Internal Medicine — Payments: $1.2M
Kenneth Binmoeller, Md, MD
Internal Medicine — Payments: $1.2M
Dr. Hope Rugo, Md, MD
Internal Medicine — Payments: $881,117
Dr. Steven Harris, M.d, M.D
Internal Medicine — Payments: $806,637
Dr. Kenneth Colley, Md, MD
Internal Medicine — Payments: $732,736